BSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.
Medplus Health Services Ltd: key numbers
- Share price
- ₹597.85
- Market cap
- ₹7,184 Cr
- Revenue (annual)
- ₹6,892 Cr
- Net profit (annual)
- ₹219.7 Cr
- P/E (TTM)
- 34.0×Sector 53.8×
- Promoter holding
- 40.19%+0.00% QoQ
- FII holding
- 12.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medplus Health Services Ltd
All →Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Medplus Health Services Board Meeting Date
MedPlus Health Services scheduled a board meeting for 6 November 2026 to consider a share buy-back. The trading window for designated persons closes from 30 October 2026.
Medplus Health Services Capital Structure Change
ICICI Prudential Mutual Fund disclosed under Regulation 29(2) that it bought 24,35,693 Medplus shares, lifting its stake to 9.21%. The acquisition was made in the open market, not off-market.
- Promoter stake change
- +1.97%
Medplus Health Services Earnings Call Transcript: Key Takeaways
Medplus reported Q2 revenue of ₹2,037.1 Cr with 21.3% pharmacy growth, but EBITDA margins were hit by state-mandated wage hikes.
- Call
- Guides 10% growth
Medplus Health Services Share Pledge
Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).
Medplus Health Services Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,037cr (+21.3% YoY), operating EBITDA ₹98cr (4.8% margin), reported PAT ₹56cr (+1% YoY). Store expansion continues; no explicit guidance given.
Other business update announcements
All →MPS Business Update
MPS Limited's Chairman and CEO, Rahul Arora, participated in a media interaction with CNBC-TV18. The discussion covered Q2FY27 financial results, business performance, and growth outlook.
Exicom Tele-Systems Business Update
Exicom Tele-Systems is consolidating manufacturing by transitioning operations from its Gurugram facility to existing plants in Hyderabad and Solan. The transition aims to optimize infrastructure and is expected to finish by November 15, 2026.
- Execution
- November 15, 2026
Kwality Pharmaceuticals Business Update
Kwality Pharmaceuticals secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This expands its EU-approved manufacturing footprint and positions it for global licensing opportunities.
Vishnu Prakash R Punglia Business Update
VPRPL entered an MoU with N.K. Gupta Builders for proposed acquisition at evaluation stage. The deal targets expansion in infrastructure and construction, including Leh & Ladakh.
Tata Consultancy Services Business Update
TCS published its Enterprise AI Study surveying 1,333 leaders across 25 countries on AI adoption. The study highlights productivity as AI's top benefit.
Allied Blenders & Distillers Business Update
ABD recorded its highest-ever monthly sales at over 3.6 million cases in October 2026. Officer's Choice Brandy and Sumo Whisky joined the millionaire club, reaching six brands.